Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
Neumayer
H H
HH
Department of Medicine-Nephrology, Humboldt University of Berlin, Germany.
Färber
L
L
Budde
K
K
Kohnen
R
R
Maibücher
A
A
Schuster
A
A
Vollmar
J
J
Waiser
J
J
Luft
F C
FC
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004304:Dosage Forms; D004655:Emulsions; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006339:Heart Rate; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors
D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine